9009:TSEKeisei Electric Railway Co., Ltd. Analysis
Data as of 2026-03-14 - not real-time
$0.56
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Shanghai Huili Building Materials trades at roughly half of its DCF‑derived fair value (~$0.56 vs $1.44), indicating a significant discount despite a modest PE of 13.9 and a strong ROE of 30%. The stock shows a bullish MACD histogram and rising volume, yet it remains below its 50‑day and 200‑day moving averages, signaling a neutral‑to‑slightly bearish medium‑term trend. Margins are exceptionally high (gross margin >92%, operating margin 60%) but revenue is contracting (-3.7%) and operating cash flow is negative, highlighting a mixed earnings picture.
The company’s balance sheet is ultra‑conservative with negligible debt and ample cash, while volatility is elevated (~50% over 30 days) but beta is low, suggesting price swings are more company‑specific than market‑driven. No dividend is paid, and the current market sentiment leans toward greed (Fear‑Greed Index 72.9), which may fuel short‑term buying pressure as price approaches the $0.578 resistance level.
The company’s balance sheet is ultra‑conservative with negligible debt and ample cash, while volatility is elevated (~50% over 30 days) but beta is low, suggesting price swings are more company‑specific than market‑driven. No dividend is paid, and the current market sentiment leans toward greed (Fear‑Greed Index 72.9), which may fuel short‑term buying pressure as price approaches the $0.578 resistance level.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Bullish MACD crossover with positive histogram
- Price testing resistance near $0.578
- High short‑term volatility
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF valuation suggests price is ~60% below fair value
- Strong ROE and ultra‑low debt
- Robust gross and operating margins
Long Term
> 3 yearsNeutral
Model confidence: 5/10
Key Factors
- Sustainable balance sheet with ample cash
- Negative revenue growth and reliance on cyclical Chinese market
- No dividend payout and modest earnings yield
Key Metrics & Analysis
Financial Health
Revenue Growth-3.70%
Profit Margin311.15%
P/E Ratio14.0
ROE30.31%
ROA2.93%
Debt/Equity0.01
P/B Ratio4.1
Op. Cash Flow$-3871984
Free Cash Flow$6.1M
Technical Analysis
TrendNeutral
RSI57.1
Support$0.45
Resistance$0.58
MA 20$0.52
MA 50$0.57
MA 200$0.57
MACDBullish
VolumeIncreasing
Fear & Greed Index72.88
Valuation
Fair Value$1.44
GradeUndervalued
TypeValue
Risk Assessment
Beta0.11
Volatility50.39%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.